Advertisement

Topics

RiverVest Venture Partners Company Profile

12:44 EST 21st November 2017 | BioPortfolio

RiverVest Venture Partners is a venture capital firm focused on identifying and shaping early-stage life science companies throughout the U.S. to create significant shareholder value. With hands-on, high-level expertise and financial resources, RiverVest supports entrepreneurs by helping them achieve near-term objectives that position their companies for exit.


News Articles [253 Associated News Articles listed on BioPortfolio]

Amplyx brings in $67mm via Series C

Antifungals developer Amplyx Pharmaceuticals Inc. raised $67mm in its Series C financing led by Sofinnova Venture Partners, which was joined by other first time backers Lundbeckfonden Ventures, Arix B...

VentureMed closes $15mm Series B

VentureMed Group Ltd. raised $15mm through its Series B financing led by first-time backer Endeavour Vision, which was joined by other new investor RiverVest Venture Partners.

RiverVest Venture Partners Expands Scientific Advisory Board

RiverVest Venture Partners announced today that Ronald T. Borchardt, Ph.D. and Jared Rutter, Ph.D. have joined the life science venture capital firm’s Scientific Advisory Board....

Managing post-amputation pain with neurostimulation, Neuros Medical raises $20M

U.S. Venture Partners led the round with participation from Boston Scientific, Aperture Venture Partners, Osage University Partners, and JumpStart.

Led by BlueCross BlueShield, Healthify Raises $6.5M for Social Determinants Management Platform

Healthify, a NYC-based community referral and social determinants management platform, closed a $6.5m Series A funding round led by BlueCross BlueShield Venture Partners (BCBSVP). The round also inclu...

GBS Venture Partners: Joshua Funder on seeing positive signs in the Australian biotech sector.

In this episode of PharmaTelevision News Review, Fintan Walton talks to Joshua Funder, Partner at GBS Venture Partners

Truveris Raises $25M for Data-Driven Platform to Transform Prescription Benefits Ecosystem

Truveris, a provider of cloud-based data analytics solutions for the prescription benefits industry has raised $25 million in Series D funding led by McKesson Ventures, and included Canaan Partners, N...

Geoff Brooke, Co-founder & Managing Partner at GBS Venture Partners

In this episode of PharmaTelevision News Review, filmed at AusBio 2012 in Melbourne, Australia, Fintan Walton talks to Geoff Brooke, Co-founder & Managing Partner at GBS Venture Partners

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]

DAY CREAM MATTIFYING HYDRATOR

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [241 Associated PubMed Articles listed on BioPortfolio]

Married to the job: working with your partner in a vet practice.

Kate Holton describes what it's like to work alongside her husband as vets and co-joint venture partners at their Vets4Pets practice in Yate.

Partners' Overestimation of Patients' Pain Severity: Relationships with Partners' Interpersonal Responses.

The present study examined whether concordance between patients' and their partners' reports of patient pain severity relates to partners' social support and behavioral responses in couples coping wit...

CSI Surrey: new integrated forensics venture launched.

A qualitative study of secondary distribution of HIV self-test kits by female sex workers in Kenya.

Promoting awareness of serostatus and frequent HIV testing is especially important among high risk populations such as female sex workers (FSW) and their sexual partners. HIV self-testing is an approa...

Male engagement in women's microbicide use in Kenya: Navigating gender norms.

The success of women's microbicide use for HIV/AIDS prevention may hinge on health programs' ability to engage men to support it. In this qualitative study in Kenya, most women did not or would not te...

Clinical Trials [251 Associated Clinical Trials listed on BioPortfolio]

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept n...

Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners

RATIONALE: Participating in a therapy program may enhance communication and intimacy between men with prostate cancer and their partners. PURPOSE: This randomized clinical trial is studyi...

Companies [1563 Associated Companies listed on BioPortfolio]

RiverVest Venture Partners

RiverVest Venture Partners is a venture capital firm focused on identifying and shaping early-stage life science companies throughout the U.S. to create significant shareholder va...

RiverVest Venture Management, LLC

RiverVest Venture Partners is a venture capital firm investing nationwide in emerging medical device, biopharmaceutical and other healthcare venture opportunities. With a total of more than 80 years o...

Stromedix, Inc.

Stromedix is a privately held biotechnology company based in Cambridge, Massachusetts, focused on innovative therapies for fibrotic organ failure. Investors in Stromedix include A...

Direct Flow Medical, Inc.

Founded in 2004, the Company is headquartered in Santa Rosa, California, has a second manufacturing facility in Lake Forest, CA and employs 75 people. The Company’s unique im...

Hatteras Venture Partners

Hatteras Venture Partners (HVP) is a venture capital firm based in Research Triangle Park, NC with a focus on seed and early stage opportunities in biopharmaceuticals, medical dev...

More Information about "RiverVest Venture Partners" on BioPortfolio

We have published hundreds of RiverVest Venture Partners news stories on BioPortfolio along with dozens of RiverVest Venture Partners Clinical Trials and PubMed Articles about RiverVest Venture Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of RiverVest Venture Partners Companies in our database. You can also find out about relevant RiverVest Venture Partners Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record